N@N

OTTAWA, ONTARIO--(Marketwire - July 14, 2010) - Chemaphor Inc. (TSX VENTURE:CFR) today launched its new website ([ www.chemaphor.com ]) to provide investors, partners, future customers, the public and other interested parties an up-to-date picture of the company's progress towards commercialization of, and insight into, its Natural Health Optimizer (NHO) platform and, in particular, its first two products, Chemaphor's Oximunol™ Chewables and the recently in-licensed Vet-Stem Regenerative Cell Therapy treatment. Dr Paul Dick, CEO Chemaphor commented "this new website is part of Chemaphor's ongoing commitment to communicate effectively and in a timely manner with various stakeholders the attainment of critical milestones and essential corporate and product information. Plans are in place to enhance the website with state of the art tools to communicate with and encourage feedback from our shareholders, our customers and the public".

About Chemaphor

Chemaphor, a wellness company, is committed to developing and delivering NHO products to humans and animals to assist in optimizing health and daily quality of life. From this platform Chemaphor is advancing product candidates for the food animal market, companion animal market and various, potential human applications. More information can be found at [ www.chemaphor.com ]

Forward Looking Statements

This news release includes certain forward-looking statements that are based upon current expectations, which involve risks and uncertainties associated with Chemaphor's business and the environment in which the business operates. Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking, including those identified by the expressions "anticipate", "believe", "plan", "estimate", "expect", "intend", and similar expressions to the extent they relate to Chemaphor or its management. The forward-looking statements are not historical facts, but reflect Chemaphor's current expectations regarding future results or events. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Chemaphor assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.